Relapsed Acute Lymphoblastic Leukemia (ALL) Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04881240	Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia	Treatment	Coenzyme M (DB09110) Cyclophosphamide (DB00531) Fludarabine (DB01073)